secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2024-08-28T23:59:59+00:00
Accession:  0001437749-24-027943
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen stockholders elect all seven director nominees, approve say-on-pay, ratify auditors at 2024 annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected, including CEO Shawn K. Singh with 14,540,841 votes for and 154,427 withheld.
- Non-binding advisory vote on executive compensation approved: 13,758,902 for, 842,393 against, 93,973 abstain.
- Ratification of KPMG LLP as independent auditor for FY2025 overwhelmingly approved: 21,277,275 for, 49,205 against.
- Meeting held August 26, 2024; results reported in 8-K filed August 28, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000143774924027943/0001437749-24-027943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000143774924027943/vtgn20240827_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-027943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer